Cardlytics Capex Per Share from 2010 to 2024

CDLX Stock  USD 3.80  0.13  3.54%   
Cardlytics Capex Per Share yearly trend continues to be fairly stable with very little volatility. Capex Per Share will likely drop to 0.27 in 2024. During the period from 2010 to 2024, Cardlytics Capex Per Share regression line of annual values had r-squared of  0.11 and arithmetic mean of  0.37. View All Fundamentals
 
Capex Per Share  
First Reported
2010-12-31
Previous Quarter
0.3396185
Current Value
0.27
Quarterly Volatility
0.11219686
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Cardlytics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cardlytics' main balance sheet or income statement drivers, such as Tax Provision of 0.0, Interest Income of 3.4 M or Depreciation And Amortization of 16.7 M, as well as many indicators such as Price To Sales Ratio of 1.03, Dividend Yield of 0.0 or PTB Ratio of 3.76. Cardlytics financial statements analysis is a perfect complement when working with Cardlytics Valuation or Volatility modules.
  
Check out the analysis of Cardlytics Correlation against competitors.
For more information on how to buy Cardlytics Stock please use our How to Invest in Cardlytics guide.

Latest Cardlytics' Capex Per Share Growth Pattern

Below is the plot of the Capex Per Share of Cardlytics over the last few years. It is Cardlytics' Capex Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cardlytics' overall financial position and show how it may be relating to other accounts over time.
Capex Per Share10 Years Trend
Slightly volatile
   Capex Per Share   
       Timeline  

Cardlytics Capex Per Share Regression Statistics

Arithmetic Mean0.37
Geometric Mean0.35
Coefficient Of Variation30.13
Mean Deviation0.08
Median0.40
Standard Deviation0.11
Sample Variance0.01
Range0.3797
R-Value(0.34)
Mean Square Error0.01
R-Squared0.11
Significance0.22
Slope(0.01)
Total Sum of Squares0.18

Cardlytics Capex Per Share History

2024 0.27
2023 0.34
2022 0.4
2020 0.37
2019 0.46
2018 0.39
2017 0.0844

About Cardlytics Financial Statements

Cardlytics investors use historical fundamental indicators, such as Cardlytics' Capex Per Share, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Cardlytics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Capex Per Share 0.34  0.27 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Cardlytics Stock Analysis

When running Cardlytics' price analysis, check to measure Cardlytics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardlytics is operating at the current time. Most of Cardlytics' value examination focuses on studying past and present price action to predict the probability of Cardlytics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardlytics' price. Additionally, you may evaluate how the addition of Cardlytics to your portfolios can decrease your overall portfolio volatility.